| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5690578 | Urology | 2017 | 21 Pages |
Abstract
Intravesical injections of OnabotulinumtoxinA compared with placebo showed a statistically significant improvement in the treatment of overactive bladder. Adverse events were more frequent among patients treated with OnabotulinumtoxinA. This meta-analysis takes into account only randomized placebo controlled trials.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Hugo López Ramos, Lynda Torres Castellanos, Ingrid Ponce Esparza, Alejandro Jaramillo, Andrea RodrÃguez, Camila Moreno Bencardino,